Abstract
Background: Gastroesophageal reflux disease (GERD) is commonly treated with magnetic sphincter augmentation (MSA) or laparoscopic fundoplication (LF). Both procedures have shown efficacy, but their short-term outcomes, including postoperative symptoms, complications, and quality of life, require further evaluation.
Aims: To compare the short-term outcomes of MSA and LF in GERD treatment, focusing on postoperative symptoms, complications, and quality of life.
Study Design: This systematic review and meta-analysis followed the PRISMA guidelines and was registered with PROSPERO (CRD42024564433).
Methods: We conducted comprehensive search on PubMed, Embase, and Google Scholar for studies comparing MSA and LF in GERD patients. A total of 11 observational cohort studies with 2,156 patients were included. We used fixed or random-effects models for statistical analyses and assessed heterogeneity with the I² index and Cochrane Q-test. Meta-regression analysis was performed to explore potential confounders.
Results: The meta-analysis included 1,332 patients who underwent MSA and 824 who underwent LF. MSA was associated with a significantly lower incidence of gas/bloat symptoms (OR=0.45, 95% CI 0.28–0.72, p=0.001). MSA also showed a higher likelihood of maintaining the ability to vomit (OR=11.4, 95% CI 7.67–16.95, p<0.00001) and belch (OR=6.40, 95% CI 4.23–9.70, p<0.00001) compared to LF. Dysphagia requiring endoscopic dilation was more common in MSA (9.3% vs. 6.52%, OR=2.03, 95% CI 1.19–3.47, p=0.010). Postoperative GERD-Health-Related Quality of Life (HRQL) scores, PPI suspension rates, and reoperation rates were comparable between the two groups.
Conclusion: Both MSA and LF are effective in managing GERD. MSA offers advantages in preserving the ability to belch and vomit, and in reducing gas-bloat symptoms, while postoperative dysphagia may be more frequent. Further randomized controlled trials are necessary to confirm these findings and establish long-term outcomes.
Keywords
Magnetic sphincter augmentation, Fundoplication, Gastroesophageal reflux disease, LINX device, Anti-reflux surgery, Health-related quality of life